Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dodwell

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 26, 2024
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic reviewMichael Jiang, Kerry Avery, Rosina Ahmed, et al.
BMJ Open|April 9, 2025
SMALL: open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer-protocol for a phase III randomised multicentre trialKenneth Elder, Charlotte Coles, David Dodwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
BMJ Open|December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodesAmit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.
American Journal of Ophthalmology|July 16, 2008
Intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, Friederike Mackensen, J Fernando Arevalo, et al.
NPJ Breast Cancer|October 29, 2025
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trialsShelley Potter, Kerry Avery, Rosina Ahmed, et al.
The Lancet. Oncology|May 9, 2017
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trialHelena M Earl, Louise Hiller, Helen C Howard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 2, 2025
Local management of second breast cancer event after primary breast conserving therapy: The patient's perspectiveJean-Michel Hannoun-Levi, Julie Margenthaler, Bethany Anderson, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 26, 2024
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic reviewMichael Jiang, Kerry Avery, Rosina Ahmed, et al.
BMJ Open|April 9, 2025
SMALL: open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancer-protocol for a phase III randomised multicentre trialKenneth Elder, Charlotte Coles, David Dodwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
BMJ Open|December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodesAmit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.
American Journal of Ophthalmology|July 16, 2008
Intravitreal bevacizumab in inflammatory ocular neovascularizationAhmad M Mansour, Friederike Mackensen, J Fernando Arevalo, et al.
NPJ Breast Cancer|October 29, 2025
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trialsShelley Potter, Kerry Avery, Rosina Ahmed, et al.
The Lancet. Oncology|May 9, 2017
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trialHelena M Earl, Louise Hiller, Helen C Howard, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 2, 2025
Local management of second breast cancer event after primary breast conserving therapy: The patient's perspectiveJean-Michel Hannoun-Levi, Julie Margenthaler, Bethany Anderson, et al.
Pageof 12